Inventor · disambiguated record
Jennifa Gosling
Also filed as: GOSLING JENNIFA
12 granted patents·7 pending applications·62 citations·filing 2000–2024
89Inventor score
Top patents by PatentIndex Score
19 records- 0197US11530229B2Cyano cyclobutyl compounds for CBL-B inhibition and uses thereofNURIX THERAPEUTICS INC·Filed 2020·Granted Dec 20, 2022·12 cites·71 claims
- 0297US11464802B23-substituted piperidine compounds for Cbl-b inhibition, and use thereofNURIX THERAPEUTICS INC·Filed 2020·Granted Oct 11, 2022·14 cites·53 claims
- 0397US11401267B2Substituted benzyl-triazole compounds for Cbl-b inhibition, and further uses thereofNURIX THERAPEUTICS INC·Filed 2020·Granted Aug 2, 2022·11 cites·32 claims
- 0494US11951133B23-substituted piperidine compounds for Cbl-b inhibition, and use thereofNURIX THERAPEUTICS INC·Filed 2022·Granted Apr 9, 2024·2 cites·36 claims
- 0592US12485144B23-substituted piperidine compounds for Cbl-b inhibition, and use thereofNURIX THERAPEUTICS INC·Filed 2024·Granted Dec 2, 2025·1 cites·40 claims
- 0692US12049471B2Cyano cyclobutyl compounds for Cbl-b inhibition and uses thereofNURIX THERAPEUTICS INC·Filed 2022·Granted Jul 30, 2024·1 cites·16 claims
- 0790US12234230B2Substituted benzyl-triazole compounds for Cbl-b inhibition, and further uses thereofNURIX THERAPEUTICS INC·Filed 2022·Granted Feb 25, 2025·1 cites·5 claims
- 0886US6998239B1Method for identifying a modulator of the binding of CCX CKR polypeptide to a chemokineCHEMOCENTRYX INC·Filed 2000·Granted Feb 14, 2006·12 cites·17 claims
- 0983US12121540B2CBL inhibitors and compositions for use in adoptive cell therapyNURIX THERAPEUTICS INC·Filed 2020·Granted Oct 22, 2024·1 cites·48 claims
- 1081US2025136590A1Substituted benzyl-triazole compounds for cbl-b inhibition, and further uses thereofNURIX THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1180US2024409555A1Cyano cyclobutyl compounds for cbl-b inhibition and uses thereofNURIX THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1269US6835547B1Methods for identifying modulators of CCX CKR activityCHEMOCENTRYX INC·Filed 2000·Granted Dec 28, 2004·7 cites·34 claims
- 1361US7108990B2Chemokine receptorCHEMOCENTRYX INC·Filed 2004·Granted Sep 19, 2006·0 cites·14 claims
- 1451US2022387395A1Urea, amide, and substituted heteroaryl compounds for cbl-b inhibitionNURIX THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1550US2005239130A1Method for identifying a modulator of the binding of CCX CKR polypeptide to a chemokineCHEMOCENTRYX INC·Filed 2005·Application pending·0 cites
- 1650US2022324835A1Inhibitors of cbl-b and methods of use thereofNURIX THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1746USRE39849EMethods for identifying modulators of CCX CKR activityCHEMOCENTRYX INC·Filed 2005·Granted Sep 18, 2007·0 cites·34 claims
- 1843US2013189262A1IL-27 Antagonists for Treating Inflammatory DiseasesWONG BRIAN·Filed 2013·Application pending·0 cites
- 1941US2012183548A1IL-27 Antagonists for Treating Inflammatory DiseasesWONG BRIAN·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jennifa Gosling files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →